Skip to search formSkip to main contentSkip to account menu

TJ-54

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Yi-Gan San

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Incidence and risk factor analysis of the postoperative delirium after gastrointestinal surgery: An exploratory analysis of a prospective, randomized phase II trial.
30Background: The postoperative complications, delirium are a particularly common morbidity after gastrointestinal surgery… 
2017
2017
Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal malignancy patients.
115Background: Delirium is one of the common postoperative complications. When postoperative delirium occurred, the patient… 
2017
2017
515PRandomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients
2017
2017
E-096 Elective carotid artery stenting for high signal lesions on mr black blood images
Background Carotid artery lesions with high signal on MR black-blood (BB) images look at high risk for symptomatic embolic… 
2013
2013
Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.
BACKGROUND Autistic disorder is a neuropsychiatric syndrome characterized by deficits in social interaction; qualitative… 
2012
2012
Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
BackgroundNumerous medications have been tested on patients with pervasive developmental disorder not otherwise specified (PDD… 
2010
2010
Yokukansan (TJ-54) ameliorates demyelination and behavioral deficits in cuprizone-induced schizophrenia mouse model
2005
2005
Effects of Yoku-kan-san on undifferentiated somatoform disorder with tinnitus
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)